Top News

  • October 22, 2014

    DaVita Finalizes $389M Settlement Over Kickback Claims

    Dialysis giant DaVita HealthCare Partners Inc. has finalized a deal in which it will pay $389 million and unwind 11 joint ventures to resolve criminal and civil claims by a whistleblower that it provided kickbacks to kidney doctors, DaVita and the U.S. Department of Justice said Wednesday.

  • October 22, 2014

    Jury Clears Apple In $94M Patent Suit Over IPhones, IPads

    Apple Inc. triumphed in GPNE Corp.'s $94 million patent trial Wednesday when a California federal jury unanimously found that the tech titan's iPhones and iPads didn't infringe two data-communications patents, though Apple failed to convince jurors that those patents are invalid.

  • October 22, 2014

    Fifth Street Pulls Plug On IPO Amid Market Volatility

    Fifth Street Asset Management Inc. called off its plans Wednesday to raise nearly $240 million in an initial public offering, citing bumpy market conditions and continued volatility for new issuers.

  • October 22, 2014

    BGC Partners Goes Hostile With $675M Bid for GFI Group

    BGC Partners Inc. said Wednesday it has launched a $675 million hostile takeover bid on for rival brokerage and trade services provider GFI Group Inc. after talks between the companies failed to result in a deal.

  • October 22, 2014

    Mylan Signals $5.3B Abbott Inversion On Track After Tweaks

    Mylan Inc. and Abbott Laboratories said Wednesday that new limitations imposed by the Obama administration on tax-motivated M&A wouldn't derail their planned $5.3 billion inversion deal, though they did modify the terms of the transaction.

  • October 22, 2014

    Blackwater Guards Found Guilty In Iraq Shooting Case

    Three former Blackwater Worldwide security guards were convicted Wednesday of manslaughter, attempted manslaughter and weapons charges while a fourth colleague was found guilty of first-degree murder stemming from their involvement in a September 2007 shooting that left 14 dead in a Baghdad traffic circle.

  • October 22, 2014

    2nd Circ. Affirms Ex-Mayer Brown Partner's Refco Fraud Rap

    The Second Circuit on Wednesday upheld the conviction and one-year sentence of former Mayer Brown LLP partner Joseph Collins, who was charged with aiding client Refco Inc.’s $1 billion accounting fraud.

  • October 21, 2014

    Apple Slams GPNE's 'Extreme' $94M Patent Bid

    Apple Inc. bashed GPNE Corp.’s $94 million damages demand as “extreme” and “unreasonable” Tuesday during closing arguments in GPNE’s trial accusing Apple of selling millions of iPhones and iPads that infringe two data-communications patents, telling a California federal jury that Apple should pay nothing.

  • October 21, 2014

    Nexium Jury Told Drug Cos. Wheeled-And-Dealed With Patent

    Nexium buyers pursuing a pay-for-delay case against AstraZeneca PLC and two generic-drug makers told a Boston federal jury on Tuesday that the pharmaceutical companies were trying to game the patent system to overcharge consumers by billions of dollars for the heartburn treatment.

  • October 21, 2014

    Buchanan Ingersoll, BofA Sued For $219M Virgin Islands Bond

    Buchanan Ingersoll & Rooney PC and Bank of America Corp. were slapped with a lawsuit by the U.S. Virgin Islands Public Finance Authority on Monday alleging they wrongly said a $219 million bond offering was tax-exempt, although an Internal Revenue Service investigation proved otherwise.

  • October 21, 2014

    JPMorgan, UBS, Credit Suisse Pay €94M Over Rate-Rigging

    The European Commission announced €94 million ($119.6 million) in settlements against J.P. Morgan, UBS, and Credit Suisse on Tuesday in connection with cartels that fixed the price of the Swiss franc-denominated Libor and certain Swiss franc interest-rate derivatives near the peak of the financial crisis.

  • October 21, 2014

    AbbVie Launches $5B Buyback After Failed Deal

    After scrapping a $55 billion merger attempt with British rival Shire PLC in the wake of a U.S. government crackdown on inversion deals, U.S. drugmaker AbbVie Inc. late Monday unveiled plans for a $5 billion stock buyback and 17 percent dividend increase to boost shareholder value.

  • October 21, 2014

    NY Fed Overlooked JPMorgan London Whale Risks: Watchdog

    The New York Federal Reserve Bank identified risks at the JPMorgan Chase unit responsible for the London Whale trading debacle, but did not share these findings with one of the bank’s other regulators, nor did it go through with planned examinations of the unit, the regulator’s internal watchdog said Tuesday.

  • October 21, 2014

    GTAT's Deal With Apple To Shed Light On Mystery Ch. 11

    Lawyers for GT Advanced Technologies Inc. and Apple Inc. announced a settlement late Tuesday that would allow GT to exit its money-losing sapphire production business and finally explain the falling-out between the onetime partners that led to its unexpected Chapter 11.

  • October 21, 2014

    Ackman Says Allergan CEO Oversaw Valeant Smear Campaign

    Activist investor Bill Ackman in a new court filing late on Monday accused Allergan Inc.'s CEO of trying to tarnish Valeant Pharmaceuticals International Inc. in an effort to sour shareholders on its hostile $53 billion bid.

  • October 20, 2014

    Trinity Bilked Feds Of $175M, Jury Finds In Guardrail FCA Suit

    A Texas federal jury Monday found that Trinity Industries Inc. defrauded the U.S. government out of $175 million by selling dangerous guardrails to the U.S. Federal Highway Administration, reaching the verdict three days after a judge refused to toss the False Claims Act case.

  • October 20, 2014

    GM Ignition Defect Death Tally Rises To 29

    More deaths have been attributed to a faulty ignition in General Motors Co. vehicles, bringing the total to 29, according to a claims report released Monday by the attorney who manages a compensation fund for victims of crashes caused by the defect.

  • October 20, 2014

    Skadden Steers Permira In $3.5B Agrochemicals Unit Sale

    Private equity firm Permira has netted  $3.51 billion through the sale of insecticide and agrochemicals maker Arysta LifeScience Ltd. to a chemical company part-owned by activist investor Bill Ackman, with assistance from Skadden, Arps, Slate, Meagher & Flom LLP, the companies said Monday.

  • October 20, 2014

    WTO Once Again Strikes Down US Meat Labeling Rules

    For the third time in three years, the World Trade Organization faulted U.S. labeling requirements for pork and beef, finding on Monday that the regulations were still discriminating against Canadian and Mexican imports despite the government's efforts to comply with earlier adverse rulings.

  • October 17, 2014

    Dish, Fox Each Say Aereo Backs Their Claims In DVR Fight

    Dish Network Corp. and Fox Broadcasting Inc. faced off in a California federal courthouse Friday, each arguing that the U.S. Supreme Court's recent Aereo ruling supports its bid for a quick win in their fight over whether Dish's Internet-streaming DVR features infringe Fox's copyrights.

Expert Analysis

  • 6 Tips For Creating Effective Trial Graphics

    Aaron Stienstra

    These days, jurors and judges are so accustomed to seeing graphics — on the street, on the Web, on their smartphones — that they expect to see something good in the courtroom. The best graphics are composed of consequential information, clearly displayed, with emphasis on what matters most, paired with artwork that adds meaning. This simultaneously compels people to think, feel and make decisions, says Aaron Stienstra, design direc... (continued)

  • Takeaways From United Technologies' $75M Settlement

    Jeffrey Gerrish

    United Technologies Corporation's global settlement with the U.S. Departments of State and Justice underscores the importance of a robust compliance program to prevent, detect and remediate any violations of export control laws or regulations — especially if products and services are destined for China, say Jeffrey Gerrish and Soo-Mi Rhee of Skadden Arps Slate Meagher & Flom LLP.

  • Understanding Mayo V. Prometheus

    William Merkel

    Following the U.S. Supreme Court's treatment of the machine-or-transformation test in Mayo Collaborative Services Inc. v. Prometheus Laboratories Inc., the test — previously thought to be the governing test for patent eligibility under § 101 — no longer appears to occupy such a prominent role in patent-eligibility jurisprudence, says William Merkel of Marshall Gerstein & Borun LLP.

  • Radlax — 'An Easy Case'

    Douglas Spelfogel

    “This is an easy case,” Justice Antonin Scalia wrote in his opinion in Radlax Gateway Hotel LLC v. Amalgamated Bank, settling the issue of whether the Bankruptcy Code grants the secured creditor a right to credit bid in an auction sale under a plan. But interestingly, the opinion barely mentions the infamous Philadelphia News decision from the Third Circuit which was effectively overruled by the U.S. Supreme Court, say attorneys wi... (continued)

  • The Latest Attempt At Criminalizing 'Robo-Signing'

    Ralph Mazzeo

    While the New York state Senate did not act on the Foreclosure Fraud Prevention Act of 2012 before adjourning its regular session — and as a result there is little chance the bill will be enacted this year — the bill represents the latest attempt by state governments to impose criminal liability on fraudulent foreclosure practices by mortgage servicers or their employees, say attorneys with Dechert LLP.

  • How The 2nd Circ. Aleynikov Opinion Went Awry

    Mark Krotoski

    In United States v. Aleynikov, the Second Circuit recently created an unfortunate cloud over the scope of the federal trade secret statute. The decision detracts from the primary legislative objectives to promote and protect national economic security and punish individuals who misappropriate intellectual property in the form of trade secrets, say Mark Krotoski and Richard Scott of the U.S. Department of Justice.

  • PPACA Victory Sets Stage For New Wave Of Litigation

    Howard Shapiro

    Although the Patient Protection and Affordable Care Act and its coverage mandates have been upheld, the lack of regulatory guidance for many key areas of the statute creates uncertainty regarding implementation and enforcement. No matter how employers and plan fiduciaries approach the various coverage mandates, it is clear that the future is not without risk of litigation, say attorneys with Proskauer Rose LLP.

  • Did The Court Get The Oracle Analysis Right?

    David Makman

    The Northern District of California's opinion in Oracle America Inc. v. Google Inc. is suprising given that there was direct copying and that the threshold of originality required for a work to qualify as copyrightable has traditionally been so low that the application programming interfaces almost certainly qualified as sufficiently original to be protected by copyright, says David Makman of the Law Offices of David A. Makman.

  • Facing CFIUS: Better Safe Than Sorry

    George Wang

    The Committee on Foreign Investment in the United States recently blocked yet another acquisition involving Chinese investors. Any foreign companies looking to invest in the U.S. should be wary of the scrutiny they may confront, and determine whether CFIUS review is likely, say George Wang and Yelena Kotlarsky of Haynes and Boone LLP.

  • A Closer Look At ING's $619M Settlement

    Ed Krauland

    ING Bank NV's $619 million fine to settle criminal charges is the largest ever against a financial institution in connection with an investigation into U.S. sanctions violations and related offenses. The enforcement action is also notable in several other respects, say attorneys with Steptoe & Johnson LLP.